Healthleap, a healthcare technology company developing artificial intelligence tools for hospitals, has raised $38 million in seed and Series A funding.
The company is developing an AI platform that analyses patient records to identify people who may have undiagnosed medical conditions and require closer attention from healthcare professionals.

The funding includes an $8 million seed round co led by Sequoia Capital and First Round Capital and a $30 million Series A led by Hummingbird Ventures.

Healthleap was founded in South Africa in 2022 by siblings Jemima and Josiah Meyer. The company initially developed a clinical nutrition tool for dietitians before expanding its focus to a broader hospital platform.

Its technology analyses information contained in electronic health records, including laboratory results, vital signs, medications and clinical notes, to identify warning signs associated with conditions such as malnutrition and delirium.

The company said its platform is currently deployed in more than 50 hospitals. Healthleap has also developed programmes aimed at identifying aspiration pneumonia, pressure ulcers and the risk of readmission for congestive heart failure.

The company stresses that its software does not diagnose patients. Instead, it identifies people who may require additional review by medical professionals.

Healthleap’s system connects to a hospital’s electronic health record and uses language models to analyse written clinical notes.

It can identify references to symptoms such as recent weight loss, poor appetite, muscle loss and difficulty swallowing, then combine that information with structured medical data to produce risk assessments.

The company said the system analyses adult inpatients overnight and provides care teams with risk scores and additional information through a dashboard the following morning.

Healthleap said it has expanded from three hospital partners to more than 50 in the past year, with customers including Penn Medicine, Cedars Sinai, Intermountain, Houston Methodist and Emory Healthcare.

The company said its revenue has increased more than tenfold during the same period. At the Hospital of the University of Pennsylvania, Healthleap said its malnutrition programme produced an estimated $23.8 million in annual financial impact.

The company plans to use the new funding to expand its engineering, product, sales and customer success teams while developing systems capable of identifying more than 40 major health conditions and eventually supporting outpatient and home care.

Source: TechCrunch